United States· US:82667-800_42679191-e5c2-90c6-e063-6294a90a93ed
TRIESENCE
A corticosteroids for local oral treatment product containing triamcinolone acetonide, registered in United States by Harrow Eye, LLC. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Triamcinolone acetonide is registered in 2 of 19 countries.
Countries holding a registration under ATC A01AC (corticosteroids for local oral treatment), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Triamcinolone acetonide · ATC A01AC
2 / 19 countries
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- triamcinolone acetonide
- Manufacturer
- Harrow Eye, LLC
- Country
- United States (US)
- ATC code
- A01AC
- ATC class
- Corticosteroids for local oral treatment
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1182667800011 BLISTER PACK in 1 CARTON (82667-800-01) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASS
Regulatory notes
Same medicine, other countries
Triamcinolone acetonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTriesenceOrifarm Oy
- GermanyKortikoidRatiopharm Gmbh
- United KingdomAdcortyl in Orabase 0.1% oromucosal pasteBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsCremor triamcinolonacetonide 0,1% Mylan, creme 1 mg/gMylan B.V.
- NorwayKenacort RetardBristol-Myers Squibb
- BelgiumAlbicort 10Sanofi Belgium
- CanadaAPO-TRIAMCINOLONE AQAPOTEX INC
- Japanトリアムシノロンアセトニドアルフレッサファーマ
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Volon, Volon A
- Belgium · Delphi, Kenacort-A
- Cyprus · Triacort
- Czechia · Triamcinolon Léčiva
- Germany · Nasacort, Rhinisan
- Denmark · Kenalog, Triamcinolone Acetonide Medipha
- Estonia · Kenalog
- Spain · Nasacort
- Finland · Nasacort, Triamcinolone Medipha
- France · Kenacort Retard, Nasacort
- United Kingdom (Northern Ireland) · Nasacort
- Greece · Jiven, Nasacort
- Croatia · Kenalog
- Hungary · Ftorocort, Kenalog
- Ireland · Nasacort, Nasacort Allergy
- Iceland · Kenacort-T, Nasacort
- Italy · Kenacort, Nasacort
- Lithuania · Ftorocort, Kenalog
- Luxembourg · Delphi, Kenacort-A
- Latvia · Ftorocort, Kenalog
- Malta · Nasacort, Nasacort Allergy
- Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
- Norway · Kenacort-T, Nasacort
- Poland · Polcortolon
- Portugal · Nasacort, Telfast Spray Nasal
- Sweden · Kenacort-T, Nasacort
- Slovenia · Kenalog
- Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f24a1168-3562-4105-9b45-d265e985e27d GET /v1/drugs/f24a1168-3562-4105-9b45-d265e985e27d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "F446C597KA",
"rxcui": "10761",
"inchikey": "YNDXUCZADRHECN-JNQJZLCISA-N",
"display_name": "TRIAMCINOLONE ACETONIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "OPHTHALMIC",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"22692d92-1359-9252-e063-6394a90ab669": {
"match": "brand_token",
"title": "TRIESENCE (TRIAMCINOLONE ACETONIDE) INJECTION, SUSPENSION [NOVARTIS PHARMACEUTICALS CORPORATION]",
"spl_version": "2",
"published_date": "2026-04-02"
}
},
"productid": "82667-800_42679191-e5c2-90c6-e063-6294a90a93ed",
"productndc": "82667-800",
"dosage_form": "INJECTION, SUSPENSION",
"orange_book": {
"appl_no": "022048",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "40MG/ML (40MG/ML)",
"product_no": "001",
"approval_date": "Nov 29, 2007"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TRIAMCINOLONE ACETONIDE",
"shortage_reason": "Triamcinolone Hexacetonide Injection",
"shortage_status": "current",
"proprietary_name": "TRIESENCE",
"active_ingred_unit": "mg/mL",
"application_number": "NDA022048",
"marketing_category": "NDA",
"nonproprietary_name": "triamcinolone acetonide",
"start_marketing_date": "20241001",
"active_numerator_strength": "40"
}See everything about triamcinolone acetonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.